{"id":519912,"date":"2021-07-29T08:33:27","date_gmt":"2021-07-29T12:33:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\/"},"modified":"2021-07-29T08:33:27","modified_gmt":"2021-07-29T12:33:27","slug":"albireo-to-report-second-quarter-2021-financial-results-on-august-5","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\/","title":{"rendered":"Albireo to Report Second Quarter 2021 Financial Results on August 5"},"content":{"rendered":"<h2>\n\u2014\u00a0Conference call and webcast to be held at 10:00 a.m. ET \u2014\u00a0<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">BOSTON, July  29, 2021  (GLOBE NEWSWIRE) &#8212; Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced that management will host a conference call and live audio webcast at\u00a010:00 a.m. ET on\u00a0August 5, 2021, to provide a business update and review the company\u2019s financial results for the second quarter ended June 30, 2021.<\/p>\n<p>To access the live conference call by phone, please dial 877-407-0792\u00a0(domestic) or 201-689-8263 (international), and provide the access code 13720893. A live audio webcast will be accessible from the Media &amp; Investors page of Albireo\u2019s website,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DRe3UfbDJ2YpLB-uIMBPeJMF0sMeerAKJLmmifvWBPelY45gnxNpP1jftYPj63XGKMI27nteBNoebuHXhDxe4XBEbGBC2Lwch_-yAX2mJyA=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/ir.albireopharma.com\/<\/a>. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes prior to the start time. An archived version of the webcast will be available for replay in the Events &amp; Presentations section of the Media &amp; Investors page of Albireo\u2019s website for 3 months following the event.<\/p>\n<p>\n        <strong>About Albireo<\/strong>\n      <\/p>\n<p>Albireo Pharma is a rare liver disease company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases. Albireo\u2019s product, Bylvay, was approved by the U.S. FDA as the first for the treatment of pruritus in patients with all sub-types of progressive familial intrahepatic cholestasis (PFIC), and is also being developed to treat other rare pediatric cholestatic liver diseases with Phase 3 trials in Alagille syndrome and biliary atresia, as well as an Open-label Extension (OLE) study for PFIC. In Europe, Bylvay has been approved for the treatment of PFIC and has been submitted for pricing and reimbursement approval. The Company has also initiated a Phase 1 clinical trial for A3907 to advance development in adult cholestatic liver disease, with IND-enabling studies moving ahead with A2342 for viral and cholestatic liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year. For more information on Albireo, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9cMoDDuOQMfR8LWPdwBMei4CfvA8YZsLc4WcX5b4mxvjkGvdwht7gYY_xBZLdyWyyQ4cR04Ohx__6jTyzj3GwRmueJM-VO0r8emVHUpgnmM=\" rel=\"nofollow noopener\" target=\"_blank\">www.albireopharma.com<\/a>.<\/p>\n<p>\n        <strong>Media Contact:<\/strong>\u00a0<br \/>Colleen Alabiso, 857-356-3905,\u00a0<u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-QCHUqWJnD34JMhtja7vKwwL_Vu5wXEUje5dgGrUe3lkrWmC5klKlTA_Msb0P2qo6quEiHWLwv8M36u-Uq0mLu9pOi6vOrQ1QdJYb7R85zhuzMQU68CjY9sTq_5qqbrs\" rel=\"nofollow noopener\" target=\"_blank\">colleen.alabiso@albireopharma.com<br \/><\/a><\/u>Lisa Rivero, 617-947-0899,\u00a0<u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=R-DOhFzr-9eYiICwaR9JLLoJw2LVURpiG9arXmZPjBOilGP4jB9_wKytWZhtE4vVOrFegXVIO4cEVsBgwR_qRFm22Y-72HoC-pCSYHuyubpGJ1QffX6YxR7veMo0IXmG\" rel=\"nofollow noopener\" target=\"_blank\">lisa.rivero@syneoshealth.com<\/a><\/u>\u00a0<\/p>\n<p>Investor Contact:\u00a0<br \/>Hans Vitzthum, LifeSci Advisors, LLC.,\u00a0617-430-7578\u00a0\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4Njg4NyM0MzE1MDQwIzIwODA2NTE=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/b9ea8c89-d42f-4869-92dd-33cdb381c8ae\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u2014\u00a0Conference call and webcast to be held at 10:00 a.m. ET \u2014\u00a0 BOSTON, July 29, 2021 (GLOBE NEWSWIRE) &#8212; Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced that management will host a conference call and live audio webcast at\u00a010:00 a.m. ET on\u00a0August 5, 2021, to provide a business update and review the company\u2019s financial results for the second quarter ended June 30, 2021. To access the live conference call by phone, please dial 877-407-0792\u00a0(domestic) or 201-689-8263 (international), and provide the access code 13720893. A live audio webcast will be accessible from the Media &amp; Investors page of Albireo\u2019s website,\u00a0https:\/\/ir.albireopharma.com\/. To ensure a timely connection to the webcast, it is recommended that &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Albireo to Report Second Quarter 2021 Financial Results on August 5&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-519912","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Albireo to Report Second Quarter 2021 Financial Results on August 5 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Albireo to Report Second Quarter 2021 Financial Results on August 5 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"\u2014\u00a0Conference call and webcast to be held at 10:00 a.m. ET \u2014\u00a0 BOSTON, July 29, 2021 (GLOBE NEWSWIRE) &#8212; Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced that management will host a conference call and live audio webcast at\u00a010:00 a.m. ET on\u00a0August 5, 2021, to provide a business update and review the company\u2019s financial results for the second quarter ended June 30, 2021. To access the live conference call by phone, please dial 877-407-0792\u00a0(domestic) or 201-689-8263 (international), and provide the access code 13720893. A live audio webcast will be accessible from the Media &amp; Investors page of Albireo\u2019s website,\u00a0https:\/\/ir.albireopharma.com\/. To ensure a timely connection to the webcast, it is recommended that &hellip; Continue reading &quot;Albireo to Report Second Quarter 2021 Financial Results on August 5&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-29T12:33:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4Njg4NyM0MzE1MDQwIzIwODA2NTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Albireo to Report Second Quarter 2021 Financial Results on August 5\",\"datePublished\":\"2021-07-29T12:33:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\\\/\"},\"wordCount\":393,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4Njg4NyM0MzE1MDQwIzIwODA2NTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\\\/\",\"name\":\"Albireo to Report Second Quarter 2021 Financial Results on August 5 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4Njg4NyM0MzE1MDQwIzIwODA2NTE=\",\"datePublished\":\"2021-07-29T12:33:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4Njg4NyM0MzE1MDQwIzIwODA2NTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI4Njg4NyM0MzE1MDQwIzIwODA2NTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Albireo to Report Second Quarter 2021 Financial Results on August 5\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Albireo to Report Second Quarter 2021 Financial Results on August 5 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\/","og_locale":"en_US","og_type":"article","og_title":"Albireo to Report Second Quarter 2021 Financial Results on August 5 - Market Newsdesk","og_description":"\u2014\u00a0Conference call and webcast to be held at 10:00 a.m. ET \u2014\u00a0 BOSTON, July 29, 2021 (GLOBE NEWSWIRE) &#8212; Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced that management will host a conference call and live audio webcast at\u00a010:00 a.m. ET on\u00a0August 5, 2021, to provide a business update and review the company\u2019s financial results for the second quarter ended June 30, 2021. To access the live conference call by phone, please dial 877-407-0792\u00a0(domestic) or 201-689-8263 (international), and provide the access code 13720893. A live audio webcast will be accessible from the Media &amp; Investors page of Albireo\u2019s website,\u00a0https:\/\/ir.albireopharma.com\/. To ensure a timely connection to the webcast, it is recommended that &hellip; Continue reading \"Albireo to Report Second Quarter 2021 Financial Results on August 5\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-29T12:33:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4Njg4NyM0MzE1MDQwIzIwODA2NTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Albireo to Report Second Quarter 2021 Financial Results on August 5","datePublished":"2021-07-29T12:33:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\/"},"wordCount":393,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4Njg4NyM0MzE1MDQwIzIwODA2NTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\/","name":"Albireo to Report Second Quarter 2021 Financial Results on August 5 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4Njg4NyM0MzE1MDQwIzIwODA2NTE=","datePublished":"2021-07-29T12:33:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4Njg4NyM0MzE1MDQwIzIwODA2NTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI4Njg4NyM0MzE1MDQwIzIwODA2NTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/albireo-to-report-second-quarter-2021-financial-results-on-august-5\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Albireo to Report Second Quarter 2021 Financial Results on August 5"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/519912","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=519912"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/519912\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=519912"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=519912"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=519912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}